Guía OncoSur de Cáncer de mama 50 > BIBLIOGRAFÍA 1. Oncoguía SEGO: Cáncer infiltrante de mama. Guías de práctica clínica en cáncer ginecológico y mamario. Madrid: SEGO; 2017. 2. GiulianoAE, Ballman K, McCall LM, Beitsch PD, Brennan MB, Kelemen PR, et al. Effect ofAxillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: TheACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017;318(10):918-26. 3. Boughey JC, McCall LM, Ballman KV, Mittendorf EA, Ahrendt GM, Wilke LG, et al. Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial. Ann Surg. 2014;260:608-14. 4. Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, et al. Sentinel lymph node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective multicentre cohort study. Lancet Oncol. 2013;14:609-18. 5. Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, et al. Sentinel node biopsy following neoadjuvant chemotherapy in biopsy proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33:258-64. 6. Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34:1072-8. 7. Karakatsanis A, Christiansen PM, Fisher L, Hedin C, Pistioli L, Sund M, et al. The Nordic SentiMag trial: a comparison of superparamagnetic iron oxid (SPIO) nanoparticles versus Tc99 and patent blue in the detection of sentinel node in patients with breast cancer and a meta-analysis of earlier studies. Breast Cancer Res Treat. 2016;157:281-94. 8. Balic M, Thomssen C, Würstlein R, Gnant M, Harbeck N. St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primery breast Cancer Treatment. Breast Care. 2019;14:103-10. 9. Donker M, Straver ME, Wesseling J, Loo CE, SchotM , Drukker CA, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg. 2015;261:378-82.
RkJQdWJsaXNoZXIy MTQzMjMwMg==